HAE(Haemonetics Corporation) · 财务报表

HAE(Haemonetics Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2022-04-02FY 截至 2023-04-01FY 截至 2024-03-30FY 截至 2025-03-29FY 截至 2026-03-28
营业收入$993.20M$1.17B$1.31B$1.36B$1.33B
毛利润$505.50M$615.10M$691.55M$748.96M$787.59M
营业利润$80.75M$156.03M$164.88M$221.82M$156.73M
净利润$43.38M$115.40M$117.56M$167.68M$97.31M
经营现金流$172.26M$273.06M$181.75M$181.72M$293.22M
自由现金流$75.75M$81.73M$143.63M$142.45M$260.44M
摊薄每股收益$0.84$2.24$2.29$3.31$2.05

Haemonetics Corporation HAE